Page last updated: 2024-10-25

deferoxamine and Hallervorden-Spatz Disease

deferoxamine has been researched along with Hallervorden-Spatz Disease in 2 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dooling, EC1
Schoene, WC1
Richardson, EP1
Gallyas, F1
Környey, S1

Other Studies

2 other studies available for deferoxamine and Hallervorden-Spatz Disease

ArticleYear
Hallervorden-Spatz syndrome.
    Archives of neurology, 1974, Volume: 30, Issue:1

    Topics: Adult; Amantadine; Autopsy; Brain; Brain Diseases; Cerebral Cortex; Deferoxamine; Electroencephalogr

1974
[A further contribution to the knowledge of the Hallervorden-Spatz disease].
    Archiv fur Psychiatrie und Nervenkrankheiten, 1968, Volume: 212, Issue:1

    Topics: Adolescent; Brain Diseases; Deferoxamine; Globus Pallidus; Humans; Iron; Iron Isotopes; Male; Molecu

1968